Table 2.
Demographic and clinical characteristics | Overall |
---|---|
n | 52 |
Age [mean (SD)] | 59.02 (13.43) |
Sex (male) (%) | 21 (40.4) |
Disease activity according to PGA (%) | |
remission | 25 (48.1) |
active disease | 24 (46.2) |
Moderate disease activity | 3 (5.8) |
Abdominal pain, frequency (%) | |
1 Less than once a week | 18 (34.6) |
2 1–2 times a week | 9 (17.3) |
3 3–6 times per week | 7 (13.5) |
4 Daily | 18 (34.6) |
Abdominal pain, duration (%) | |
1 <30 min | 17 (32.7) |
2 0.5 h to 1 h | 7 (13.5) |
3 1–6 h | 6 (11.5) |
4 >6 h | 22 (42.3) |
Abdominal pain, severity (%) | |
0 No pain | 12 (23.1) |
1 Mild pain | 8 (15.4) |
2 Moderate pain | 7 (13.5) |
3 Severe pain | 4 (7.7) |
4 Very severe pain | 21 (40.4) |
Number of additional symptoms (%) (choose any of the following: bloating, tenesmus, change in bowel habits) | |
0 | 11 (21.2) |
1 | 18 (34.6) |
2 | 6 (11.5) |
3 | 17 (32.6) |
Missed activities during last 2 weeks (%) | 24 (46.2) |
Woken up at night during last 2 weeks (%) | 23 (44.2) |
Experienced lack of energy in last 2 weeks (%) | 32 (61.5) |
Felt anxious or depressed in last 2 weeks (%) | 24 (46.2) |
Felt the need to change treatment in last 2 weeks (%) | 23 (44.2) |
PGA, physician global assessment; SD, standard deviation.